Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer - Poll - MDSpire

Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer

  • By

  • Xinglong Lu

  • Xiang Cui

  • Hao Chen

  • Jianling Zhang

  • Shengbing Zhao

  • Baoshun Yang

  • Yang Yang

  • Nan Du

  • Wenxiang Ma

  • Jixi An

  • Yongjiang Yu

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer

  • by Xinglong Lu, Xiang Cui, Hao Chen, Jianling Zhang, Shengbing Zhao, Baoshun Yang, Yang Yang, Nan Du, Wenxiang Ma, Jixi An, Yongjiang Yu

  • May 25, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

High-grade astrocytoma with piloid features: a case report of comprehensive management